Pernix Therapeutics, Inc. (PTX) Completes Divesture of Non-Core Assets to Breckenridge Pharmaceutical, Inc.  
9/12/2013 10:06:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HOUSTON--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ MKT: PTX), a specialty pharmaceutical company, today announced that it had completed the previously disclosed sale of certain non-core assets to Breckenridge Pharmaceutical, Inc.

Help employers find you! Check out all the jobs and post your resume.